Duration of illness [years] | 8.35 ± 6.56 |
C-reactive protein (CRP) [mg/l] | 17.47 ± 17.23 |
Rheumatoid factor (RF) [IU/ml] | 163.83 ± 329.98 |
Anti-cyclic citrullinated peptide (anti-CCP) [EU/ml] | 333.69 ± 479.44 |
Seropositivity [n/%] | 19 / 63.3 |
Disease activity index DAS28 | 6.48 ± 0.52 |
Collective assessment of health by the patient and the doctor (VAS) | 82.50 ± 4.08 |
Neutrophil gelatinase-associated lipocalin (NGAL) [ng/ml] | 12.79 ± 8.80 |
Steroids [n/%] | 20/66.7 |
Methotrexate [n/%] | 22/73.3 |
Other disease-modifying drugs [n/%] | 12/40.0 |
Salazopyrin | 1/3.3 |
Leflunomide | 7/23.3 |
Cyclosporine | 3/10.0 |
Chloroquine | 1/3.3 |